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Abstract: Mosquitoes, such as Aedes aegypti, can transmit arboviruses to humans. The exogenous
short interfering RNA (exo-siRNA) pathway plays a major antiviral role in controlling virus infection
in mosquito cells. The Dicer 2 (Dcr2) nuclease is a key effector protein in this pathway, which cleaves
viral double-stranded RNA into virus-derived siRNAs that are further loaded onto an effector called
Argonaute 2 (Ago2), which as part of the multiprotein RNA-induced silencing complex (RISC) targets
and cleaves viral RNA. In order to better understand the effector protein Dcr2, proteomics experiments
were conducted to identify interacting cellular partners. We identified several known interacting
partners including Ago2, as well as two novel and previously uncharacterized Ae. aegypti proteins.
The role of these two proteins was further investigated, and their interactions with Dcr2 verified by
co-immunoprecipitation. Interestingly, despite their ability to interact with Ago2 and Piwi4, neither
of these proteins was found to affect exo-siRNA silencing in a reporter assay. However, one of these
proteins, Q0IFK9, subsequently called aBravo (aedine broadly active antiviral protein), was found to
mediate antiviral activity against positive strand RNA arboviruses. Intriguingly the presence of Dcr2
was not necessary for this effect, suggesting that this interacting antiviral effector may act as part of
protein complexes with potentially separate antiviral activities.
Keywords: mosquito; Aedes aegypti; arbovirus; antiviral response
1. Introduction
Mosquitoes transmit many medically and economically relevant arboviruses, including those
belonging to the Flaviviridae and Togaviridae (genus Alphavirus) families, as well as those of the order
Bunyavirales (previously Bunyaviridae family) [1–8].
Arboviruses actively replicate in mosquito cells, where immune responses counteract these
processes. One of the most important antiviral defense mechanisms in mosquitoes is RNA interference
(RNAi), which acts via sequence-specific target RNA breakdown mechanisms. There are two RNAi
pathways in mosquitoes induced upon viral infection: the exogenous small interfering RNA (exo-siRNA)
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and the PIWI-interacting RNA (piRNA) pathways [9–14]. The exo-siRNA pathway is particularly
important and has been shown to mediate antiviral activity. Viral RNA replication results in the
synthesis of double-stranded RNA (dsRNA), which are targeted by the nuclease Dicer 2 (Dcr2) that
slices these dsRNAs into mostly 21 nucleotide (nt) long virus-specific siRNA (vsiRNAs) in insects.
Following this, vsiRNAs are loaded to the Argonaute 2 (Ago2) protein, which is part of the multiprotein
RNA-induced silencing complex (RISC). One strand of the vsiRNA duplex is degraded and the
remaining strand guides Ago2 to complementary viral RNA strand, resulting in its cleavage and
degradation, assuming that mechanisms in mosquitoes resemble those of Drosophila melanogaster [15–18].
The production of vsiRNAs has been identified in arbovirus-infected mosquitoes, as well as in their
derived cell lines for alpha-, flavi-, and bunyaviruses, and indeed Dcr2 and Ago2 can act antivirally
against various arboviruses in mosquitoes or derived cell lines [9,11,12]. A possible exception might be
Zika virus (ZIKV, Flaviviridae), which may at least to some extent be resistant to Ago2 activity, though
it is still targeted by Dcr2 [19–21].
Virus-specific piRNAs (vpiRNAs) have been detected in mosquitoes and mosquito-derived
cell lines following infection by viruses of all major arbovirus families/orders [10,12]. piRNAs are
single-stranded and 24–29 nt in length and produced independently of Dicer activities. The primary
role of piRNAs in most tested insects, is considered to be controlling transposons in germline
cells. Most knowledge on the insect piRNA pathway is based on the D. melanogaster model, where
piRNAs are produced in ovary follicular cells or in nurse cells; however, this is not applicable to
mosquitoes [10,22–26]. Indeed, in mosquitoes, piRNAs are also produced in somatic cells and can
be transposon, gene, or virus-specific. In addition, there has been an expansion of the PIWI protein
family in mosquitoes, where Ae. aegypti has 8 (Piwi1-7 and Ago3) compared to the 3 PIWI proteins
(Aub, Piwi, and Ago3) of D. melanogaster [27,28]. Although Piwi5, Piwi6, and Ago3 are mostly required
for virus-derived piRNA production in mosquito, the only strongly antiviral PIWI protein in Ae. aegypti
is Piwi4. However, its role in piRNA production and piRNA binding is not well understood and
possibly disputable [19,29–32].
In general, there are gaps in our understanding of the regulation of the insect exo-siRNA pathway.
Only recently, the Domino ortholog p400 was shown to regulate Ago2 levels in Ae. aegypti [33]. Neither
are interactions of RNAi effectors with cellular partners characterized, bar a few exceptions. Protein
interactions are often critical to understanding how and where an antiviral effector, such as Dcr2, acts,
and, in the context of the exo-siRNA pathway, this therefore justifies further investigation. Indeed, Dcr2
is a major antiviral protein in mosquitoes, yet its interaction partners are not characterized in vector
cells. Besides, there are likely differences from D. melanogaster. Indeed, studies so far have shown
that, in the D. melanogaster siRNA pathway model, Dcr2 interacts with R2D2 and Loquacious (Loqs)
proteins, which is required for linking steps from dsRNA cleavage to Ago2 loading, where Hsc70/Hsp90
chaperone machinery plays an important role [34–45]. Intriguingly, in Ae. aegypti Loqs2, paralogue
of Loqacious and R2D2 is required for antiviral activity against dengue virus (DENV, Flaviviridae) in
midguts [46].
The lack of data with regards to this pathway in Ae. aegypti has largely been due to lack of
available tools, such as antibodies against mosquito proteins, expression systems, etc. Recent work by
us and others have resulted in the establishment of novel tools to stably express proteins in aedine
cells, including tagged proteins, which permits their capture.
In the current study, we used such a previously established cell line, an Ae. aegypti-derived Aag2
cell line that stably expresses Ae. aegypti Dcr2 [32] to identify interaction partners and thus potentially
new antiviral proteins, given that Dcr2 plays a critical role in insect immunity.
Using a label-free quantitative proteomics approach, we identified two novel partners in addition
to several RNAi-pathway members known in D. melanogaster: Ago2, Hsc70-3 (orthologue of human
GRP78), Loquacious (LOQs), and R2D2. cDNA sequences were amplified, cloned, and expressed;
the interaction between Dcr2 and the two novel partners was confirmed by co-immunoprecipitation.
One of the proteins, which we called aBravo (aedine broadly active antiviral protein), was found
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to have antiviral properties against alphaviruses (Semliki Forest [SFV] and chikungunya [CHIKV]),
as well as the flavivirus ZIKV. Interestingly, neither protein appeared to be involved in RNA silencing.
This suggests that antiviral complexes in mosquito cells may consist of interacting proteins that carry
out independent functions but may detect viral patterns within one complex.
2. Materials and Methods
2.1. Cells
Ae. aegypti-derived Aag2 cells (a kind gift of Paul Eggleston, Keele University, Keele, UK) were
grown in L-15 medium plus Glutamax (Thermo Fisher Scientific, Waltham, MA, USA) supplemented
with 10% tryptose phosphate broth (TPB; Thermo Fisher Scientific, Waltham, MA, USA), 10% fetal
bovine serum (FBS; Thermo Fisher Scientific, Waltham, MA, USA), and penicillin–streptomycin (final
concentrations of 100 units/mL and 100 µg/mL, respectively; Thermo Fisher Scientific, Waltham,
MA, USA) at 28 ◦C. For Aag2-derived cell lines expressing V5-tagged proteins enhanced green
fluorescent protein (eGFP), Dcr2, Ago2, and Piwi4 (Dcr2 GeneBank ID: AAW48725, Ago2 GeneBank
ID: ACR56327 and Piwi4 sequence derived from Aag2 cells) [32], zeocin (Thermo Fisher Scientific,
Waltham, MA, USA) was added to a final concentration of 100 µg/mL to main the expression of
gene of interest. Ae. aegypti-derived Dcr2 KO cells (AF319) and the parental cell line AF5 [32] were
grown in the same conditions as Aag2 cells. BHK-21 cells were used to propagate SFV and CHIKV
and were grown in Glasgow minimum essential medium (Thermo Fisher Scientific, Waltham, MA,
USA) supplemented with 10% TPB, 10% FBS, and penicillin–streptomycin (final concentrations of
100 units/mL and 100 µg/mL, respectively) at 37 ◦C, 5% CO2. A549-NPro cells (a kind gift of R. E.
Randall, University of St. Andrews, St. Andrews, UK) were grown in Dulbecco’s Modified Eagle’s
medium (DMEM; Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 10% FBS, 2 µg/mL
puromycin, penicillin-streptomycin (final concentration 100 units/mL, 100 µg/mL, respectively); to
grow and titrate ZIKV, puromycin was left out [47].
2.2. Plasmids and Viruses
The firefly luciferase (FFLuc) and Renilla luciferase (Rluc) expression plasmids pIZ-Fluc and
pAcIE1-Rluc, respectively, have been previously described [48]. The plasmid pPUb (with Ae. aegypti
polyubiquitin promoter to direct gene expression) was used to generate the reminder of the expression
constructs [32]. Target genes of interest from cDNA synthesized on total RNA isolated from Aag2
cells; a myc-tag sequence was added to the N-terminus of the protein during cloning. Plasmid
pCMV-SFV4(3H)-FFLuc, contains reporter virus cDNA based on the SFV4 clone of SFV, virus
SFV4(3H)-FFLuc expresses FFLuc as part of its non-structural polyprotein and is liberated by viral
nsP2 [32,49]. Wild-type SFV4 was rescued from plasmid pCMV-SFV4 [50]. pSP6-ICRES1-2SG-FFLuc
construct is based on LR2006OPY1 strain of CHIKV belonging to East/Central/South African
genotype [31]; in this virus, FFLuc is expressed from duplicated subgenomic promoter. ZIKV strain
PE243 used in this study was isolated in Brazil [51].
2.3. Protein Immunoprecipitation
Immunoprecipitation (IP) was carried out as previously described [32]. Briefly, 3 × 107 cells
stably expressing V5-eGFP or V5-Dcr2 were scraped and collected, followed by washing with
phosphate-buffered saline (PBS). Thereafter, the cells were resuspended in lysis buffer (150 mM NaCl,
5 mM MgCl2, 20 mM HEPES (pH 7.4), 0.5% Triton X-100, protease inhibitor cocktail (Thermo Fisher
Scientific, Waltham, MA, USA). Cells were kept on ice for 20 min, followed by centrifugation at
15,000× g at 4 ◦C for 25 min. The supernatant was then transferred into fresh tubes on ice, and mouse
anti-V5 (1:500; AB27671; Abcam, Cambridge, UK) was added to the supernatant. Tubes were rotated
for 2 h, at 4 ◦C. Following this, G-coated magnetic beads (Dynabead protein G; Thermo Fisher Scientific,
Waltham, MA, USA) were added per sample after the beads had been equilibrated with cold washing
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buffer (150 mM NaCl, 5 mM MgCl2, 20 mM HEPES [pH 7.4], 0.5% Triton X-100). Tubes were then
again rotated for 1 h, at 4 ◦C. The samples were washed 4 times with cold washing buffer. After the
final wash, beads were resuspended in sample buffer (per 100 µL of buffer 25 µL of 4× Bolt lithium
dodecyl sulfate sample buffer, 10 µL of 10× Bolt reducing agent (Thermo Fisher Scientific, Waltham,
MA, USA) 65 µL of H2O) and boiled at 95 ◦C for 10 min. Protein samples were analyzed at Glasgow
Polyomics on an LTQ-Orbitrap Elite instrument (Thermo Fisher Scientific, Waltham, MA, USA) coupled
to UltiMate 3000 RSLCnano System chromatography system (Thermo Fisher Scientific, Waltham, MA,
USA). Sample processing and analysis were carried out as previously described [47]. Interactors were
identified using MaxQuant software and search conducted against UniProt database of Ae. aegypti
proteins. For each protein, label-free quantification was carried out, and MaxQuant software-specific
LFQ values were obtained; a protein was considered an interactor if present in samples with at least
two peptides.
For co-immunoprecipitation, 107 cells in a T75 flask stably expressing the protein of interest were
transfected with 10 µg of plasmid expressing myc-tagged protein in pPUb using Dharmafect 2 reagent
(Horizon Discovery, Cambridge, UK). At 48 h post-transfection (p.t.), immunoprecipitation was carried
out as described above with the exception that mouse anti-myc antibody (1:500; catalog number 2276;
Cell Signaling Technology, Danvers, MA, USA) was used.
2.4. Western Blot Analysis
Samples were run on Bolt 4–12% Bis-Tris Plus gels (Thermo Fisher Scientific, Waltham, MA,
USA) and transferred to 0.45 µm nitrocellulose membrane (Thermo Fisher Scientific, Waltham, MA,
USA) using a Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad, Hercules, CA, SA). Five percent (w/v)
non-fat dry milk in Tween-PBS (PBS with 0.1% Tween 20) was used to block membranes for at least
1 h. Membranes were probed with mouse anti-myc tag antibody (2276; Cell Signaling Technology,
Danvers, MA, USA) or mouse anti-V5 antibody (AB27671; Abcam, Cambridge, UK) in 2% (w/v) non-fat
dry milk in Tween-PBS over-night at 4 ◦C. Following three Tween-PBS washes, the membranes were
incubated with anti-mouse secondary antibody conjugated with horseradish peroxidase (A16072; Life
Technologies, Inc.) or goat anti-mouse DyLight 800 (SA5-35521, Thermo Fisher Scientific, Waltham,
MA, USA) in 2% (w/v) non-fat dry milk in Tween-PBS for 1 h. Membranes were again washed
three times with Tween-PBS; horseradish peroxidase signal detected on Bio-Rad Chemidoc system
(Bio-Rad, Hercules, CA, USA) using chemiluminescence detection reagents (Thermo Fisher Scientific,
Waltham, MA, USA) or alternatively on Odyssey CLx (LI-COR Biosciences, Lincoln, NE, USA) to
detect fluorescence.
2.5. cDNA Synthesis and qRT-PCR
Trizol (Thermo Fisher Scientific, Waltham, MA, USA) was used to isolate total cellular RNA.
The RNA was used for cDNA synthesis using SuperScript III (Thermo Fisher Scientific, Waltham, MA,
USA) and oligo(dT)15 primer (Promega, Madison, WI, USA) or random hexamer primer (Promega,
Madison, WI, USA), depending on experiment. qRT-PCR for aedine genes or the housekeeping
gene S7 was performed on cDNA produced using oligo(dT)15 primer by utilizing gene specific
primers (Supplementary Table S1), SYBR green master mix (Thermo Fisher Scientific, Waltham, MA,
USA), and an ABI7000 Fast system (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA,
USA) according to the manufacturer’s guidelines. Alternatively, samples produced using random
hexamer primers were used to analyze ZIKV replication with virus specific primers and S7 primers for
normalization. Results were analyzed using the ∆∆CT method.
2.6. Transfection of Nucleic Acids
All transfections were carried out using Dharmafect 2 reagent (Horizon Discovery, Cambridge,
UK). To silence host transcripts and assess effect on virus replication, 1.5–1.7 × 105 Aag2 cells per well
were grown in 24-well plates, transfected with 300 ng of gene-specific dsRNAs per well, followed by
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virus infections at 24 h p.t. To silence a host gene in AF5 or AF319 cells by using siRNAs, 20 pmol of
siRNAs (Horizon Discovery, Cambridge, UK) were used per well of 24-well plate (Supplementary
Table S1). For RNAi reporter assays Aag2 cells were grown in 48-well plates and mock-infected or
infected with SFV4 at a multiplicity of infection (MOI) of 10; 6 h later, 150 ng of dsRNA against eGFP
or host targets were transfected using Dharmafect 2; at 48 h p.t., 50 ng of pIZ-Fluc and 50 ng of
pAcIE1-Rluc were co-transfected with 0.25 ng of dsRNAs (FFLuc specific or LacZ specific) or 0.25 ng
of ng siRNA (targeting FFLuc or Hygromycin B resistance gene as control [32]) using Dharmafect 2,
and the FFLuc and Rluc activities were measured 24 h later.
2.7. dsRNA Production
Gene-specific primers flanked by T7 RNA polymerase promoter sequences (Supplementary
Table S1) were used to amplify unique gene-specific fragments that were validated through Sanger
sequencing. PCR products were then used for in vitro transcription using the RNAi Megascript kit
(Thermo Fisher Scientific, Waltham, MA, USA) according to manufacturer’s instructions. The obtained
RNAs were treated with Dnase1 and RNaseA and purified using columns provided with the kit.
Previously described and verified dsRNAs were used for silencing of Ago2, Piwi4, eGFP, and
LacZ [19,29,31–33,52,53]; alternatively, new silencing dsRNAs were developed for newly identified
host proteins (see Supplementary Table S1).
2.8. Luciferase Assays
Aag2 cells were lysed with passive lysis buffer (Promega) and FFLuc activity measured by using
the Luciferase Assay System (Promega, Madison, WI, USA) for SFV4(3H)-FFLuc and the Steady-Glo
luciferase assay (Promega) for CHIKV-2SG-FFLuc. To measure both FFLuc and Rluc activities in RNAi
sensor assays, the Dual Luciferase Reporter Assay System (Promega, Madison, WI, USA) was utilized.
Luciferase activities were determined on a GloMax luminometer (Promega, Madison, WI, USA).
2.9. Statistical and Data Analyses
All luciferase data from three independent repeats were presented as mean with standard error
relative to controls. All qRT-PCR CT values from four independent experiments were normalized
to S7 housekeeping gene. Following the ∆∆CT method, normalized CT values were expressed as
mean relative RNA levels to controls with standard error. If needed values were log-transformed to
observe conditions for two-tailed Student’s t-test at 0.05 level of confidence. All statistical analyses
were performed in GraphPad Prism v.7 (GraphPad Software, San Diego, CA, USA). BLAST algorithm
at National Center for Biotechnology Information (NCBI) (https://blast.ncbi.nlm.nih.gov/Blast.cgi)
was used to search for protein homologs with default parameters, last assessed on 18th May of 2020.
Conserved Domain Database of NCBI (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) was
last used on 18th of May 2020 to identify conserved protein domains. Gene accession numbers are
given as in VectorBase database (https://www.vectorbase.org/) with Ae. aegypti assembly AaegL5.
Multiple sequence alignment (MSA) and phylogenetic tree was made using Geneious Prime v.2020.1.2
software (Biomatters, Ltd, Auckland, New Zealand).
2.10. Data Availability
Data underlying luciferase and qRT-PCR figures are available here: http://dx.doi.org/10.5525/gla.
researchdata.1010.
3. Results
3.1. Identification of Dcr2 Interactors and Antiviral Activities
Here, we used our previously developed Aag2 cell lines that stably express V5-tagged Ae. aegypti
Dcr2 or enhanced green fluorescent protein (eGFP) [32] to conduct a proteomics study in order to
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identify cellular interaction partners of Dcr2. Samples from eGFP expressing cells were used as control,
in order to identify the non-specific binders to magnetic beads and IP antibody. Those were used for
subtracting, in the next step, to identify potential partners of Dcr2 and eliminate false positives.
A protein was considered of interest if it was identified in at least 2 out of 3 replicates in Dcr2 IP
samples, and no more than once in the eGFP control. For protein identification at least two peptides
were needed (Supplementary Table S2 and summarized in Figure 1A). Among several proteins,
we identified Ago2, Loqs protein, R2D2 and Hsc70-3. Their homologs in D. melanogaster that are known
interaction partners of Dcr2 or otherwise involved in RNAi are discussed above. We also identified
poly(A)-binding protein (PABP), ribosomal protein lateral stalk subunit P2 (RPLP2) and two previously
uncharacterized Ae. aegypti proteins, with accession numbers Q17D57 and Q0IFK9 as per Uniprot
database. BLAST algorithm search against the National Center for Biotechnology Information (NCBI)
database indicated that neither of these proteins have well-characterized homologs in D. melanogaster.
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Target gene mRNAs were amplified by PCR from cDNA, and we successfully cloned these
genes into pPUb expression vector with the proteins tagged at the N-terminus with a myc-tag.
Q0IFK9 was identical at the amino acid level to AAEL004699-PA in VectorBase, however, Q17D57 was
found to have 6 amino acid differences compared to AAEL004317-PA in this database (for sequences,
see Supplementary File S1). To verify their interaction with Dcr2, the Aag2 cell line expressing
V5-tagged Dcr2 was transfected with expression constructs as indicated, followed by IP using myc-tag
specific antibody. Unlike myc-tagged eGFP, myc-Q17D57 and myc-Q0IFK9 pulled down Dcr2,
thus verifying the proteomics results (Figure 1B). Since Dcr2 is a major antiviral protein, we aimed
to test whether these two novel proteins can interact with other antiviral proteins, as well. For this,
we used V5-tagged Ago2- or V5-tagged Piwi4-expressing cell lines, and we indeed found that both
aedine proteins interacted with Ago2 and Piwi4 (Figure 1B).
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Analysis for conserved protein domains, indicated that Q17D57 contains a TRF4 domain found in
DNA polymerase sigma, and a nucleotidyltransferase domain of the poly(A) polymerase of Cid1 family
(Figure 2). Cid1 proteins can regulate the production and degradation of microRNAs (miRNAs) [54,55].
It is therefore likely that Q17D57 is related to terminal uridylyltransferase protein Tailor found in the
D. melanogaster, which has Cid1 domain, despite low sequence similarity [56]. Q0IKF9 has multiple
RNA recognition motifs at the N-terminal half of the protein (Figure 2A), though no predictions could
be made about potential functions.
Viruses 2020, 12, x 7 of 15 
 
Analysis for conserved protein domains, indicated that Q17D57 contains a TRF4 domain found 
in DNA polymerase sigma, and a nucleotidyltransferase domain of the poly(A) polymerase of Cid1 
family (Figure 2). Cid1 proteins can regulate the production and degradation of microRNAs 
(miRNAs) [54,55]. It is therefore likely that Q17D57 is related to terminal uridylyltransferase protein 
Tailor found in the D. melanogaster, which has Cid1 domain, despite low sequence similarity [56]. 
Q0IKF9 has multiple RNA recognition motifs at the N-terminal half of the protein (Figure 2A), though 
no predictions could be made about potential functions. 
Importantly, both proteins Q17D57 and Q0IFK9 appeared to lack homologs in D. melanogaster. 
The BLAST algorithm on NCBI server identified only one homolog for Q17D57 (with no known 
function) in Ae. albopictus mosquitoes. Q0IFK9 has homologs, also with no known functions, in Ae. 
albopictus, Culex quinquefasciatus, Anopheles gambiae, nor An. sinensis mosquitoes, which indicates 
conservation and potentially important role(s) in mosquitoes (phylogenetic tree, Supplementary 
Figure S1; multiple sequence alignment, Supplementary File S2; both produced by using Geneious 
software). 
 
Figure 2. Description of novel Aedes aegypti Dcr2 interactors. Conserved protein domains based on 
National Center for Biotechnology Information (NCBI) Conserved Domain Database in Q0IFK9 (A) 
and Q17D57 (B). 
Next, we tested whether Q17D57 and Q0IFK9 had any antiviral activity in the Ae. aegypti-derived 
Aag2 cell line. Cells were transfected with sequence-specific dsRNA to successfully silence Q17D57 
or Q0IFK9 (Figure 3A). Infection with FFLuc expressing SFV at MOI 0.01 indicated that Q0IFK9 was 
antiviral as shown by higher levels of luciferase at 48 h post infection (h p.i.) following silencing, 
compared to eGFP-specific dsRNA control cells (Figure 3B). An increase in luciferase was also 
observed following silencing of Piwi4, as expected. Similarly, for CHIKV (MOI 0.01), higher luciferase 
levels were measured for Q0IFK9 and Piwi4 silenced cells (Figure 3C). The effects of silencing of 
Piwi4 or Q0IFK9 on SFV or CHIKV cannot be compared directly; for the former, the luciferase 
reporter is expressed as a part of non-structural polyprotein and liberated by virus nsp2 proteolytic 
cleavage, and, in the case of latter, the reporter is expressed under the control of a duplicated 
subgenomic promoter. As the mode of action of Q0IFK9 is not known, the amplitude of effect(s) on 
viral replication may be affected by the position of the reporter gene. For ZIKV infection (MOI 0.1), a 
small but significant increase in viral RNA levels was measured by qRT-PCR at 72 h p.i. after Q0IFK9 
silencing compared to control cells (Figure 3D). Taken together, these results indicate that Q0IFK9 
acts as an antiviral protein against these positive strand RNA viruses. No increase in luciferase (for 
SFV or CHIKV) nor RNA levels (ZIKV) RNA was observed in Q17D57 silenced cells compared to 
control cells (Figure 3B, C, D). 
Figure 2. Description of novel Aedes aegypti Dcr2 interactors. Conserved protein domains based on
National Center for Biotechnology Information (NCBI) Conserved Domain Database in Q0IFK9 (A)
and Q17D57 (B).
Importantly, both proteins Q17D57 and Q0IFK9 appeared to lack homologs in D. melanogaster.
The BLAST algorithm on NCBI server identified only one homolog for Q17D57 (with no known function)
in Ae. albopictus mosquitoes. Q0IFK9 has homologs, also with no known functions, in Ae. albopictus,
Culex quinquefasciatus, Anopheles gambiae, nor An. sinensis mosquitoes, which indicates conservation
and potentially important role(s) in mosquitoes (phylogenetic tree, Supplementary Figure S1; multiple
sequence alignment, Supplementary File S2; both produced by using Geneious software).
Next, we tested whether Q17D57 and Q0IFK9 had any antiviral activity in the Ae. aegypti-derived
Aag2 cell line. Cells were transfected with sequence-specific dsRNA to successfully silence Q17D57
or Q0IFK9 (Figure 3A). Infection with FFLuc expressing SFV at MOI 0.01 indicated that Q0IFK9 was
antiviral as shown by higher levels of luciferase at 48 h post infection (h p.i.) following silencing,
compared to eGFP-specific dsRNA control cells (Figure 3B). An increase in luciferase was also observed
following silencing of Piwi4, as expected. Similarly, for CHIKV (MOI 0.01), higher luciferase levels
were measured for Q0IFK9 and Piwi4 silenced cells (Figure 3C). The effects of silencing of Piwi4 or
Q0IFK9 on SFV or CHIKV cannot be compared directly; for the former, the luciferase reporter is
expressed as a part of non-structural polyprotein and liberated by virus nsp2 proteolytic cleavage, and,
in the case of latter, the reporter is expressed under the control of a duplicated subgenomic promoter.
As the mode of action of Q0IFK9 is not known, the amplitude of effect(s) on viral replication may be
affected by the position of the reporter gene. For ZIKV infection (MOI 0.1), a small but significant
increase in viral RNA levels was measured by qRT-PCR at 72 h p.i. after Q0IFK9 silencing compared to
control cells (Figure 3D). Taken together, these results indicate that Q0IFK9 acts as an antiviral protein
against these positive strand RNA viruses. No increase in luciferase (for SFV or CHIKV) nor RNA
levels (ZIKV) RNA was observed in Q17D57 silenced cells compared to control cells (Figure 3B–D).
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Figure 3. Effect of Q17D57and Q0IFK9 silencing of Semliki Forest (SFV), chikungunya (CHIKV), and
Zika virus (ZIKV) replication. (A) Aag2 cells were transfected with double-stranded RNAs (dsRNAs) to
silence transcripts encoding Q17D57, Q0IFK9, or enhanced green fluorescent protein (eGFP) as control;
silencing efficiency was assessed by qRT-PCR on total RNA isolated 24 h p.t., using ∆∆C method and
ribosomal S7 as housekeeping gene. The mean values of three independent experiments with standard
error are shown. Transfected cells were infected with SFV(3H)-FFluc (B) or CHIKV-2SG-FFLuc (C) at
multiplicity of infection (MOI) 0.01, 24 h p.t. and lysed at 48 h p.i.; FFLuc activities were determined and
presented as relative mean luciferase activity values (normalized to activity in eGFP dsRNA treated
control); the error of the mean from three independent experiments conducted in triplicate are shown.
(D) Cells transfected as described above were infected with ZIKV PE243 at MOI 0.1 and total RNA
isolated at 72 h p.i. to quantify viral RNA levels (S7 used as housekeeping gene). The mean values of
four independent experiments with standard error are shown. For statistical analysis, values in (B)
and (C) were log-transformed to reduce the heterogeneity; * indicates significance, p < 0.05 (Student’s
two-tailed t-test).
3.2. Effects of Dcr2 Interactors on the Exo-siRNA Pathway
The antiviral action of Q0IFK9 might be exerted via the exo-siRNA pathway, given the interactions
with Dcr2 and Ago2. Hence, we next assessed if knock down of Q0IFK9 had an effect in a reporter
assay, which is based on i ucing the exo-siRNA pathway. Ago2, Piwi4, Q17D57, Q0IFK9 expression
was silenced in Aag2 cells, followed by transfection f FFLuc and Rluc expressing plasmids together
with dsRNA targeting FFluc (or LacZ as control; dsFluc or dsLacZ, respectively). In transfected cells,
dsRNA is processed into si s by Dcr2, then l aded to Ago2 followed cleavage of targ t RNA.
As expect d, in cells where Ago2 had been knocked down, silencing of FFLuc by specific dsRNAs
was significantly hampered (Figur 4A). As Piwi4 is not connected directly to th siRNA pathway,
a expected knock down had no effect on dsRNA-bas d luciferase s lencing. K ock down of neither
Q17D57 nor Q0IFK9 affected the dsRNA-based silencing efficiency on FFluc (Figure 4A).
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transf cted with (A,B) dsRNA targeting eGFP (c ntrol), Ago2, Piwi4, Q17D57 or Q0IFK9, or (C,D)
first infected with SFV4 at MOI 10 followed by dsRNA transfection 6 h later. After 48 h, cells were
co-tra sfected with FLuc (pIZ-Fluc) and Rluc (pAcIE1-Rluc) expressing r porter plasmids and (A,C)
dsRNAs against c (dsFluc) or LacZ (dsLacZ) (as control) o alternatively, (C,D) small i terfering
RNAs (siRNAs) targeting FFLuc (siFluc) or Hygromy in B resistanc gene (siHyg as control) o assess
the silencing abili y of siRNAs and bypass the necessit for Dcr2 processing. Cells were lysed at 24 h
p.t., and luciferase ct vities determined. Rel tive lucif rase levels are shown on the Y-axis (with
FFLuc/Rluc r tio in dsL cZ or siHyg transfected cells set to 1). The mean valu s with sta dard error
are s own for three independent experiment conducted in triplicate, * indicates significance, p < 0.05
(Student’s two-tailed t-t st).
Similar results were obtained if siRNAs instead of dsRNAs were used. No effect on silencing was
detected if Piwi4, Q17D57 or Q0IFK9 had been silenced (Figure 4B), unlike Ago2. We also tested if the
presence of replicating virus could affect the functioning of Q17D57 or Q0IFK9. The presence of SFV4
(MOI 10) did not affect the reporter assay (Figure 4C,D); as previously observed in uninfected cells,
the knock down of Ago2 had a substa tial effect on the exo-siRNA machinery.
These findings suggested that antiviral functions of Q0IFK9 were not connected to the exo-siRNA
pathway. In order to investigate this further, experiments were con ucted in Dcr2 k ock out cell lines
AF319, or the parental cell line AF5 which is derived from Aag2 cells [32,57]. dsRNAs cannot be used
i F319 cells due to the absence of Dcr2; thus, two different siRNAs were designed to knock down of
Q0IFK9 i AF319 and AF5 cells (Figure 5A). Infection of the cells with SFV(3H)-FFLuc, showed that
silencing of Q0IFK9 i AF5 cells resulted in increased virus replication, as measured at 24 and 48 h
p.i. compared to control cells (Figure 5B). This is similar to results obtained with dsRNAs in Aag2
cells (Figure 3B). Furthermore, a similar effect was found to occur in AF319 cells at both time points
and with both Q0IFK9 specific siRNAs, which suggests that Q0IFK9-mediated antiviral activity is
independent of the presence of Dcr2.
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4. Discussion
The exo-siRNA pathway is very important in the mosquito antiviral defense, and Dcr2 is a key
effector at the first step of this pathway. However, a majority of the Dcr2 functional studies have been
carried out in D. melanogaster and not in mosquitoes. For D. melanogaster, Dcr2 has several interaction
partners whose functions have been described (i.e., Ago2, R2D2, Loqs; the two latter having a critical
paralogue in Ae. aegypti missing in the midgut) in the siRNA pathway [34–40,42–46]. However, little is
known about mosquito proteins that interact with this antiviral protein and its possible subsequent
role(s) in processes, such as cutting dsRNAs into siRNAs and their transfer to Ago2.
Immunoprecipitation followed by mass spectrometry identified interaction partners of Ae. aegypti
Dcr2 in cells derived from this mosquito, to the best of our knowledge this the first study of this
kind. Among the captured proteins were Loqs and R2D2, as expected from work on D. melanogaster.
Interestingly, two of the identified proteins (Q17D57 and Q0IFK9) had been predicted to be expressed
in Ae. aegypti cells but not D. melanogaster. Both proteins were cloned, expressed, and shown to
co-immunoprecipitate with Dcr2, confirming their interactions. Interestingly they also interacted with
other antiviral RNAi proteins, Ago2 and Piwi4. However, it is not known whether these interactions
are direct or indirect. The interaction network between various RNAi pathways in mosquito cells is
being untangled at the moment. For example, Piwi4 can interact with Ago2 and Dcr2, as well as with
proteins of the piRNA pathway, like Ago3 [32]. This suggests that different RNAi effectors complexes
are present in cells, that might have different functions. It remains to be elucidated in future studies
how the interactions between Q17D57, Q0IFK9, Dcr2, Ago2, and Piwi4 occur directly or indirectly,
for example, via RNA bridges. Importantly, through our exo-siRNA reporter assay, we indicated
that none of the newly identified proteins had a role in facilitating gene expression silencing via
dsRNAs/siRNAs.
The C-terminal part of Q17D57 is similar to D. melanogaster terminal uridylyltransferase protein
Tailor, which carries out uridylation of miRNAs that results in their degradation [56]. However,
the N-terminus of protein Q17D57 has no sequence elements with known functional importance,
and the full-length protein was found to be conserved only in Aedes mosquitoes. Thus, it is likely that
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Q17D57 has similar function to Tailor, which could be a topic for further studies. Alternatively, in
D. melanogaster polyadenylation of Toll and R2D2 mRNA happens via Dcr2-dependent mechanism,
as Dcr2 interacts with cytoplasmic poly(A) polymerase Wispy [58]. Considering that Q17D57 has a
conserved nucleotidyltransferase domain of poly(A) polymerases, it might be that Ae. aegypti Dcr2
could have similar function in recognizing mRNAs and directing their polyadenylation. As we are not
sure about the function, we propose at this stage to name this protein aDiuf (aedine Dcr2 interactor of
unknown function).
Q0IFK9 has multiple RNA recognizing domains in its N-terminal half; however, there are
no conserved domains with known function in the C-terminal half. It was found to be antiviral
against alphaviruses, SFV and CHIKV, and the flavivirus ZIKV. Silencing did not negatively affect
dsRNA-mediated silencing of gene-expression, and its antiviral activity was found to be independent
of Dcr2. As Q0IFK9 interacts with Piwi4, we cannot exclude that it may act together with Piwi4 in
a complex that has antiviral activities. However, in general, the antiviral role of piRNAs is unclear.
The production of piRNAs that is dependent on Ago3, Piwi5 but less on Piwi6, is not needed for
the antiviral activity of Piwi4 [29,31,32]. In infected cells, viral RNA can be converted into vDNA by
transposon reverse transcriptases and Piwi4 binds piRNAs that are derived from these vDNA [30,59].
However, it needs to be determined if Q0IFK9 has a role in this process. This protein may also act
independently of any of those pathways. More work is needed to determine the mechanism(s) of
Q0IFK9 antiviral activity, but we believe that the data demonstrate that the various antiviral proteins
interact at least at some point as part of multiprotein complexes that mediate antiviral activities. Given
Q0IFK9 action against alphaviruses and a flavivirus, we propose to name this protein aBravo (aedine
broadly active antiviral protein). Future experiments should investigate the effect(s) of aBravo in vivo,
and its mode of action at molecular level. This could include identifying interaction partners of aBravo
by employing proteomics tools, but also RNA binding partners by using approaches, such as CLIP-seq.
Moreover, its cellular localization during viral replication will need to be investigated.
In summary, our proteomics-based approach revealed a novel effector in Ae. aegypti antiviral
immunity. The tools generated will allow further studies on this protein and mode(s) of action.
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